Decolonization to Reduce After-Surgery Events of Surgical Site Infection - Trial NCT05586776
Access comprehensive clinical trial information for NCT05586776 through Pure Global AI's free database. This Phase 4 trial is sponsored by University of California, Irvine and is currently Not yet recruiting. The study focuses on Surgical Site Infection. Target enrollment is 2700 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of California, Irvine
Timeline & Enrollment
Phase 4
Jan 01, 2023
Dec 01, 2028
Primary Outcome
Time to First Post-Discharge Surgical Site Infection
Summary
The DECREASE SSI Trial (Decolonization to Reduce After-Surgery Events of Surgical Site
 Infection) is a two-arm multi-center individual placebo-controlled randomized (2,700
 participants randomized 1:1) clinical trial to reduce post-discharge surgical site infection
 following open colon or small bowel surgery by comparing chlorhexidine bathing plus nasal
 mupirocin in the 30 days following discharge to soap without antiseptic properties (placebo)
 and placebo nasal ointment. This trial seeks to enhance the care of the 675,000 patients
 annually who undergo colon and small bowel surgery by finding simple and efficacious
 interventions to reduce SSI.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05586776
Non-Device Trial